Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038362 (
stomatitis
)
8,852
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The RNA-editing enzyme
ADAR1
is a double-stranded RNA (dsRNA) binding protein that modifies cellular and viral RNA sequences by adenosine deamination.
ADAR1
has been demonstrated to play important roles in embryonic erythropoiesis, viral response, and RNA interference. In human hepatitis virus infection,
ADAR1
has been shown to target viral RNA and to suppress viral replication through dsRNA editing. It is not clear whether this antiviral effect of
ADAR1
is a common mechanism in response to viral infection. Here, we report a proviral effect of
ADAR1
that enhances replication of vesicular
stomatitis
virus (VSV) through a mechanism independent of dsRNA editing. We demonstrate that
ADAR1
interacts with dsRNA-activated protein kinase PKR, inhibits its kinase activity, and suppresses the alpha subunit of eukaryotic initiation factor 2 (eIF-2alpha) phosphorylation. Consistent with the inhibitory effect on PKR activation,
ADAR1
increases VSV infection in PKR+/+ mouse embryonic fibroblasts; however, no significant effect was found in PKR-/- cells. This proviral effect of
ADAR1
requires the N-terminal domains but does not require the deaminase domain. These findings reveal a novel mechanism of
ADAR1
that increases host susceptibility to viral infection by inhibiting PKR activation.
...
PMID:Double-stranded RNA deaminase ADAR1 increases host susceptibility to virus infection. 1707 86
Two size forms of
ADAR1
adenosine deaminase are known, one constitutively expressed (p110) and the other interferon (IFN)-induced (p150). To test the role of
ADAR1
in viral infection, HeLa cells with
ADAR1
stably knocked down and 293 cells overexpressing
ADAR1
were utilized. Overexpression of p150
ADAR1
had no significant effect on the yield of vesicular
stomatitis
virus. Likewise, reduction of p110 and p150
ADAR1
proteins to less than approximately 10 to 15% of parental levels (
ADAR1
-deficient) had no significant effect on VSV growth in the absence of IFN treatment. However, inhibition of virus growth following IFN treatment was approximately 1 log(10) further reduced compared to
ADAR1
-sufficient cells. The level of phosphorylated protein kinase PKR was increased in
ADAR1
-deficient cells compared to
ADAR1
-sufficient cells following IFN treatment, regardless of viral infection. These results suggest that
ADAR1
suppresses activation of PKR and inhibition of VSV growth in response to IFN treatment.
...
PMID:RNA adenosine deaminase ADAR1 deficiency leads to increased activation of protein kinase PKR and reduced vesicular stomatitis virus growth following interferon treatment. 1991 73
Measles virus (MV), a member of the family Paramyxoviridae and an exclusively human pathogen, is among the most infectious viruses. A progressive fatal neurodegenerative complication, subacute sclerosing panencephalitis (SSPE), occurs during persistent MV infection of the CNS and is associated with biased hypermutations of the viral genome. The observed hypermutations of A-to-G are consistent with conversions catalyzed by the adenosine deaminase acting on RNA (
ADAR1
). To evaluate the role of
ADAR1
in MV infection, we selectively disrupted expression of the IFN-inducible p150
ADAR1
isoform and found it caused embryonic lethality at embryo day (E) 11-E12. We therefore generated p150-deficient and WT mouse embryo fibroblast (MEF) cells stably expressing the MV receptor signaling lymphocyte activation molecule (SLAM or CD150). The p150(-/-) but not WT MEF cells displayed extensive syncytium formation and cytopathic effect (CPE) following infection with MV, consistent with an anti-MV role of the p150 isoform of
ADAR1
. MV titers were 3 to 4 log higher in p150(-/-) cells compared with WT cells at 21 h postinfection, and restoration of
ADAR1
in p150(-/-) cells prevented MV cytopathology. In contrast to infection with MV, p150 disruption had no effect on vesicular
stomatitis
virus, reovirus, or lymphocytic choriomeningitis virus replication but protected against CPE resulting from infection with Newcastle disease virus, Sendai virus, canine distemper virus, and influenza A virus. Thus,
ADAR1
is a restriction factor in the replication of paramyxoviruses and orthomyxoviruses.
...
PMID:RNA editing enzyme adenosine deaminase is a restriction factor for controlling measles virus replication that also is required for embryogenesis. 2159 18
Adenosine deaminases acting on RNA (ADARs) catalyze the C-6 deamination of adenosine (A) to produce inosine (I), which behaves as guanine (G), thereby altering base pairing in RNAs with double-stranded character. Two genes, adar1 and adar2, are known to encode enzymatically active ADARs in mammalian cells. Furthermore, two size forms of
ADAR1
are expressed by alternative promoter usage, a short (p110) nuclear form that is constitutively made and a long (p150) form that is interferon inducible and present in both the cytoplasm and nucleus. ADAR2 is also a constitutively expressed nuclear protein. Extensive A-to-G substitution has been described in mouse polyomavirus (PyV) RNA isolated late times after infection, suggesting modification by ADAR. To test the role of ADAR in PyV infection, we used genetically null mouse embryo fibroblast cells deficient in either
ADAR1
or ADAR2. The single-cycle yields and growth kinetics of PyV were comparable between adar1(-/-) and adar2(-/-) genetic null fibroblast cells. While large T antigen was expressed to higher levels in adar1(-/-) cells than adar2(-/-) cells, less difference was seen in VP1 protein expression levels between the two knockout MEFs. However, virus-induced cell killing was greatly enhanced in PyV-infected adar1(-/-) cells compared to that of adar2(-/-) cells. Complementation with p110 protected cells from PyV-induced cytotoxicity. UV-irradiated PyV did not display any enhanced cytopathic effect in adar1(-/-) cells. Reovirus and vesicular
stomatitis
virus single-cycle yields were comparable between adar1(-/-) and adar2(-/-) cells, and neither reovirus nor VSV showed enhanced cytotoxicity in adar1(-/-)-infected cells. These results suggest that
ADAR1
plays a virus-selective role in the host response to infection.
...
PMID:Host response to polyomavirus infection is modulated by RNA adenosine deaminase ADAR1 but not by ADAR2. 2163 55